We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Targeting the Engine Room of the Cancer Cell

News   Jun 19, 2018 | Original story from Columbia University Irving Medical Center (CUIMC)

 
Targeting the Engine Room of the Cancer Cell

The pipeline consists of a series of pre-computed (*) components, including a reference set of more than 13,000 tumor expression profiles representing 35 different tumor types, a collection of 28 tissue context-specific interactomes and a database of context-specific mechanism of action (MoA) for >400 FDA-approved drugs and investigational compounds in oncology. The transcriptome of the perturbed cell lines is profiled at low cost by PLATE-Seq. The process begins with the expression profile of a single patient sample, which is compared against the tumor databank to generate a tumor gene expression signature. This signature is interpreted by VIPER using a context-matched interactome to identify the set of most dysregulated proteins, which constitute the regulators of the tumor cell state -- tumor checkpoint. These proteins are then aligned against the drugs' and compounds' MoA database, to prioritize compounds able to invert the activity pattern of the tumor checkpoint. Credit: CUIMC/Califano Lab

 
 
 

RELATED ARTICLES

Guarding Against Cancer

News

Researchers from the University of Dundee have shown that a drug previously used to treat Type II diabetes could potentially be used to protect against cancer.

READ MORE

Muscle Stem Cell Growth Growth Driver May Be Valid Target for Wasting Disorders

News

Lying within our muscles are stem cells, invisible engines that drive the tissue’s growth and repair. Understanding the signal(s) that direct muscle stem cells to spring into action could uncover new ways to promote muscle growth.

READ MORE

Technology Senses How Parkinson's Patients Respond to Medication

News

Researchers have developed an innovative way to automatically and reliably detect and monitor medication "on" and "off" states in Parkinson's disease patients.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE